Enter inventor name

Jorma Haβfeld

This inventor holds 8 USPTO granted patents. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Intellectual Property Gmbh, Piramal Imaging Sa. Active years: 2014-2018.

USPTO Granted Patents = 8

% Patents Active = 37.5

Average Co-Inventor Count = 10.2

ph-index = 4

Forward Citations = 52(Granted Patents)

Location History:

Dusseldorf, DE (2016)
Düsseldorf, DE (2014 - 2017)
Düsseldorg, DE (2018)

Company Filing History:

6 out of 386

Bayer Pharma Aktiengesellschaft

patents

1 out of 721

Bayer Intellectual Property Gmbh

Years Active: 2014-2018

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10052312 - Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2018-08-21),

2. 9624214 - Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2017-04-18),

3. 9598417 - (Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use (2017-03-21),

4. 9359306 - Process for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation (2016-06-07),

5. 9238631 - Radiolabeled amino acids for diagnostic imaging (2016-01-19),

6. 9126998 - Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2015-09-08),

7. 8946215 - Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2015-02-03),

8. 8778964 - Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use (2014-07-15),

Title: Jorma Haβfeld: Innovator in Medicinal Chemistry

Introduction

Jorma Haβfeld is a distinguished inventor based in Düsseldorf, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for the treatment of cardiovascular disorders. With a total of 8 patents to his name, Haβfeld's work has had a notable impact on pharmaceutical research and development.

Latest Patents

Among his latest patents, Haβfeld has focused on amino-substituted imidazo[1,2-a]pyridinecarboxamides and their applications. These novel compounds are designed for the treatment and/or prophylaxis of various diseases, especially cardiovascular disorders. The patents detail processes for their preparation and their potential use in creating medicaments aimed at improving patient outcomes.

Career Highlights

Throughout his career, Jorma Haβfeld has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bayer Pharma and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to refine his expertise in drug development and patenting.

Collaborations

Haβfeld has collaborated with several professionals in his field, including Alexandros Vakalopoulos and Markus Follmann. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Jorma Haβfeld's innovative work in medicinal chemistry and his contributions to the development of new therapeutic agents underscore his importance as an inventor. His patents reflect a commitment to improving healthcare through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]